» Articles » PMID: 26156052

Epidemiology of Multiple Sclerosis in the Pediatric Population of Sardinia, Italy

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2015 Jul 10
PMID 26156052
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Conclusion: Our pMS data among Sardinians corroborate the epidemiological scenario described in the adult population being the incidence estimates significantly higher than those reported elsewhere.

What Is Known: Sardinia is one of the regions at the highest risk for MS worldwide in the adult population. To date, no definite data exist on the pediatric population.

What Is New: The pediatric MS incidence in Sardinia is estimated to be significantly higher than those reported elsewhere. The pediatric MS prevalence in Sardinia is among the highest values worldwide.

Citing Articles

HERVs Endophenotype in Autism Spectrum Disorder: Human Endogenous Retroviruses, Specific Immunoreactivity, and Disease Association in Different Family Members.

Bo M, Carta A, Cipriani C, Cavassa V, Simula E, Huyen N Microorganisms. 2025; 13(1).

PMID: 39858776 PMC: 11767913. DOI: 10.3390/microorganisms13010009.


Epidemiology and Healthcare Utilization in Pediatric Multiple Sclerosis and Neuromyelitis Optica: A Nationwide Population-Based Study in South Korea (2016-2020).

Woo H, Hwang J, Choi S, Chae S Children (Basel). 2024; 11(5).

PMID: 38790547 PMC: 11119460. DOI: 10.3390/children11050553.


Multiple sclerosis in a 4-year-old boy: a case report and literature review.

Arkar U, Vipotnik Vesnaver T, Osredkar D, Perkovic Benedik M, Bizjak N Front Neurol. 2024; 15:1359938.

PMID: 38585366 PMC: 10996918. DOI: 10.3389/fneur.2024.1359938.


Epidemiological and clinical features of pediatric-onset multiple sclerosis: A population-based study in Isfahan, Iran, between 1997-2020.

Etemadifar M, Abhari A, Yadegarfar G, Salari M, Ghazavi M, Rayani M Curr J Neurol. 2023; 20(4):222-228.

PMID: 38011448 PMC: 9107569. DOI: 10.18502/cjn.v20i4.8348.


Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life.

Prajjwal P, M D M M, Natarajan B, Inban P, Gadam S, Sowndarya D Ann Med Surg (Lond). 2023; 85(9):4433-4441.

PMID: 37663711 PMC: 10473341. DOI: 10.1097/MS9.0000000000000930.


References
1.
Gorman M, Healy B, Polgar-Turcsanyi M, Chitnis T . Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol. 2009; 66(1):54-9. DOI: 10.1001/archneurol.2008.505. View

2.
Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M . Multiple sclerosis in children: clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol. 2007; 6(10):887-902. DOI: 10.1016/S1474-4422(07)70242-9. View

3.
Ketelslegers I, Catsman-Berrevoets C, Neuteboom R, Boon M, van Dijk K, Eikelenboom M . Incidence of acquired demyelinating syndromes of the CNS in Dutch children: a nationwide study. J Neurol. 2012; 259(9):1929-35. PMC: 3432787. DOI: 10.1007/s00415-012-6441-6. View

4.
Gadoth N . Multiple sclerosis in children. Brain Dev. 2003; 25(4):229-32. DOI: 10.1016/s0387-7604(03)00035-4. View

5.
Mikaeloff Y, Caridade G, Assi S, Suissa S, Tardieu M . Prognostic factors for early severity in a childhood multiple sclerosis cohort. Pediatrics. 2006; 118(3):1133-9. DOI: 10.1542/peds.2006-0655. View